The efficacy of bFGF treatment for neonatal hypoxic-ischemic injury.

BFGF treatment of neonatal hypoxic-ischemic encephalopathy observed BFGF is a large polypeptide. It can pass through the blood-brain barrier, possibly due to the immaturity of the newborn's blood-brain barrier. Hypoxic ischemia further damages brain tissue, so that bF (acting on the brain tissue in the process of governance boils. There are no obvious side effects, the drug is safe, it is felt that bFGF treatment of H...

(Note: The original text appears to have some incomplete or unclear segments, such as "bF (acting on the brain tissue in the process of governance boil" and "it is felt that bFGF treatment of H". These parts may require clarification from the source material for a more accurate translation.)